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The aim of this study was to determine if the distribution of Langerhans cells (LC) and 
interstitial dendritic cells (IDC) is altered in AIDS-associated oral Kaposi’s sarcoma when 
compared to HIV-negative highly vascular oral lesions. Fifty-one cases of AIDS-associated 
oral Kaposi’s sarcoma and 20 of highly vascular oral lesions were retrospectively retrieved. 
All cases of Kaposi’s sarcoma were confirmed with immunoreactions against CD34 
and HHV-8. Clinical data regarding sex, age and lesions location were obtained from 
pathology reports. Immunohistochemistry against CD207 (immature dendritic cells) 
and CD83 (mature dendritic cells) were done. LC were in the epithelium and IDC in the 
stroma. CD207+ cells predominated in the epithelium of the lesions, whereas CD83+ 
cells predominated in their stromal compartment. Kaposi’s sarcoma had a lower CD207+ 
immature LC count (p=0.02) and an increased CD207+ IDC than highly vascular oral 
lesions (p<0.001). Moreover, Kaposi’s sarcoma also showed an increased number of mature 
CD83+ IDC than highly vascular oral lesions (p<0.001). There were significant alterations 
in the distribution of LC and IDC in AIDS-associated Kaposi’s sarcoma when compared to 
HIV-negative vascular oral lesions, suggesting that changes in their concentrations may 
play a role in the pathogenesis of Kaposi’s sarcoma.
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Introduction
Kaposi’s sarcoma was first described by Dr. Moritz 
Kaposi and is defined as an intermediate-grade vascular 
malignancy always associated with HHV-8 infection (1). 
Incidence of Kaposi’s sarcoma had a significant increase 
after the Acquired Immunodeficiency Syndrome (AIDS) 
burden early in the 1980’s, followed by a decrease 
with HAART development. Kaposi’s sarcoma is classified 
according to its epidemiological features as classic, endemic, 
immunodeficiency- and AIDS-associated disease, as well as 
according to its clinical stage of development as macule, 
patch or nodule Kaposi’s sarcoma (2,3). In all these scenarios, 
the neoplasm is microscopically characterized by an intense 
vascular proliferation with a spindle cell component and 
chronic inflammatory infiltrate. However, microscopic 
findings may also give rise to different histological 
subtypes recognized in both cutaneous and oral mucosa 
presentations and include solid, lymphangioma-like, 
telangiectatic, desmoplastic, lymphangiectatic, ecchymotic, 
and anaplastic variants (4).
Kaposi’s sarcoma is considered the most common 
neoplasm in the HIV infection context; nevertheless, in 
spite of the important improvements in the understanding 
of its pathogenesis, some authors still consider Kaposi’s 
sarcoma as a reactive lesion, especially because of its 
potential to disappear after HAART. Although the complex 
inflammatory background of the disease is considered 
a major component in its behavior, the importance of 
dendritic cells (DC) remains elusive and very few studies 
investigated the participation of these cells in Kaposi’s 
sarcoma development.
In the skin and oral mucosa, Langerhans cell (LC) 
represents the most important antigen presenting cells 
(APC) located in the overlying epithelium, responsible 
to capture and exhibit foreign antigens to T-cells and, 
therefore, activating immune responses. When LC shifts to 
connective tissue during their movement to regional lymph 
nodes, they present morphological changes and are termed 
interstitial dendritic cells (IDC), which are also stromal 
resident cells (5). Our group has previously demonstrated 
that HIV-positive patients had a decreased concentration of 
LC and IDC in the mucosa of the oral tongue, predisposing 
these patients to a myriad of opportunistic infections (6,7). 
In addition, recent evidences pointed towards different 
DC subtypes as important agents for HHV-8 infection, 
which in turn would cause disturbances in the maturation, 
proliferation and function of these APC.
Current data on the importance of DC in the 
pathogenesis of KS are mostly derived from cutaneous 
lesions and from in vitro assays. In addition, plasmacytoid 
DC is the most investigated DC in the context of Kaposi’s 
sarcoma and HHV-8 infection. Therefore, considering the 
previous reports observing DC disturbances in Kaposi’s 
sarcoma and the lack of studies investigating this cellular 













population in the oral manifestation of the neoplasm, the 
aim of this study was to determine if the distribution of LC 
and IDC is altered in AIDS-associated oral Kaposi’s sarcoma 
when compared to HIV-negative highly vascular oral lesions.
Material and Methods
Samples
In a 30 year-period from 1985 to 2015, 51 formalin-
fixed, paraffin-embedded cases of Kaposi’s sarcoma were 
retrospectively retrieved from the files of the Oral Pathology 
Department of the School of Dentistry of the University 
of Pretoria (Pretoria/South Arica). New 5-μm-thick 
histological sections stained with hematoxylin and eosin 
were jointly revised by two oral pathologists to confirm 
the original diagnoses that were further confirmed with 
positive immunohistochemical reactions for HHV-8 and 
CD34. Clinical data regarding age, sex and tumor location 
were retrieved from the patients’ pathology reports. As a 
comparative group, 10 cases of oral pyogenic granuloma 
and 10 oral hemangiomas were retrieved from the files of 
the Oral Diagnosis Department (Pathology) of the Piracicaba 
Dental School of the University of Campinas (Piracicaba/
Brazil). All cases presented the overlying epithelial tissue 
available to quantify the presence of Langerhans cells, 
although almost all cases also demonstrated focal areas 
of ulceration. Clinical data regarding age, sex and lesions 
location were also retrieved from the pathology reports.
Immunohistochemistry
Immunohistochemical reactions against HHV-8, CD34, 
CD83 and CD207 were done in 3 µm histological sections 
of all cases. Samples were dewaxed with xylene and then 
hydrated in an ethanol series. For HHV-8 and CD34 the 
antigen retrieval was performed using EDTA /TRIS (pH 
9.0), whereas for CD83 and 207 the antigen retrieval was 
done with citrate solution (pH 6.0). Endogenous peroxidase 
activity was blocked using 10% hydrogen peroxide and 
after PBS buffer wash (pH 7.4) slides were incubated 
overnight with primary antibodies against HHV-8 (Clone: 
13B10, NOVACASTRA, Nussloch, Germany, diluted 1:50), 
CD34 (Clone: QBEnd-10, DakoCytomation, Carpinteria, 
CA, USA, diluted 1:50), CD83 (Polyclonal, Santa Cruz 
Technology, California, USA, diluted 1:100) and CD207 
(Polyclonal, Cell Marque, diluted 1:50). All slides were 
subsequently exposed to avidin-biotin complex, horseradish 
peroxidase reagents (LSAB Kit-DakoCytomation), and 
diaminobenzidine tetrahydrochloride (DAB, Sigma, St. Louis, 
MO, USA), and subsequently counter-stained with Carazzi 
hematoxylin. As positive controls, histological sections of 
intestine (blood vessel endothelium) were used for CD34, a 
previously diagnosed Kaposi’s sarcoma was used for HHV-8, 
histological sections of normal skin were used for CD207 
and normal lymph nodes were used for CD83. Negative 
controls were obtained by omitting the primary antibodies.
Immunohistochemical quantification
Quantification of LC was performed by a previously 
trained observer that counted the number positive cells 
in the surface epithelium and for IDC, positive cells were 
counted in the stroma of the lesions, far from the areas 
of ulcerations. In both counting, 10 sequential fields (40x) 
for each antibody were selected. Because of the ramified 
aspect of LC in the epithelium, morphological appearance of 
stained cells were also considered during the quantification 
process in order to avoid that one same cell was counted 
twice. The results were expressed as number of positive 
cells per case.
Statistical Analysis 
The values were expressed as mean ± standard deviation 
(SD) and as median (minimum and maximum values) for 
each group of lesions. Normality distribution of the results 
was investigated with Kolmogorov-Smirnov and Shapiro-
Wilk tests, whereas Levene test was used to determine 
the homoscedasticity of the groups. The comparison of 
the cells distribution between Kaposi’s sarcoma vs highly 
vascular oral lesions (hemangioma + pyogenic granuloma) 
was done using Student t-Test and Mann-Whitney test. 
A p-value<0.05 was considered statistically significant. 
The software SPSS version 22.0 was used for the analyses. 
This study was approved by the Ethics Committee of the 
Piracicaba Dental School, University of Campinas (protocol 
2.164.568/2017).
Results
In this study 51 cases of AIDS-associated oral Kaposi’s 
sarcoma were used. Men and women were affected in the 
same proportion (M:F ratio 1:1) with a mean age of 31 years-
old (range from 21 to 61 years-old) and a site predilection 
for the palate (21 cases), followed by the tongue (15 cases) 
and the gingiva (15 cases). Highly vascular oral lesions were 
retrieved to be used as a comparative group. Hemangioma 
comprised 10 cases, more commonly affecting females (M:F 
ratio 3:1) with a mean age of 57 years-old (range from 
46 to 78 years-old) affecting the tongue (4 cases), lips (5 
cases) and cheek mucosa (1 cases). Pyogenic granuloma 
accounted for 10 cases mostly affecting males (M:F ratio 
2:1) with a mean age of 45.6 years-old (range from 18 to 
87 years-old) always affecting the gingiva. There was no 
AIDS or HIV-positive patient in the highly vascular oral 
lesions group.
Microscopically, all 71 cases used in this study had the 
overlying epithelium present. Oral Kaposi’s sarcoma was 
predominantly composed of proliferating spindle-cells with 






















the presence of variably sized blood vessels. Erythrocytes 
extravasation was commonly found, whereas mitosis 
figures were scarce. All cases were positive for CD34 and 
HHV-8 (Fig. 1). Hemangiomas exhibited blood vessels 
with different sizes being classified as either capillary 
or cavernous hemangioma. Pyogenic granulomas were 
characterized by the presence of the granulation tissue 
with intense chronic inflammatory infiltrate and a large 
number of blood vessels.
Immunohistochemically, both markers (CD207 and 
CD83) were predominantly found in the periphery of the 
lesions and more present in ulcerated areas, therefore, 
the cell counting was done distant from these regions. 
The expression of CD207 identified immature DC mostly 
in the overlying epithelium of all lesions, whereas only a 
few cells were found inside the lesions (Fig. 2). An opposite 
expression pattern was seen for CD83, which stained mature 
DC predominantly in the middle of the lesions, with only 
scattered cells in the epithelium (Fig. 3).
Immature CD207+ LC located in the epithelium 
presented their characteristic cytoplasm extensions and 
were found in all layers, whereas mature CD83+ LC in the 
epithelium, CD207+ immature IDC and CD83+ mature 
IDC in the middle of the lesions, lost their extensions and 
usually presented as round to oval cells. 
Data on the mean (±standard deviation) and median 
(range) values obtained for CD207 in the epithelium and 
stroma of oral Kaposi’s sarcoma and highly vascular oral 
lesions are summarized in (Table 1) In the epithelium, the 
number of immature CD207+ LC was significantly higher 
in highly vascular oral lesions than in Kaposi’s sarcoma 
(p=0.02), whereas in the stroma of the lesions the number of 
immature IDC in Kaposi’s sarcoma was higher than in benign 
lesions (p<0.001). Regarding the distribution of mature 
CD83+ LC and IDC, it was not observed any statistically 
significant difference between Kaposi’s sarcoma and benign 
vascular lesions when the epithelium compartment was 
investigated (p=0.373), but the presence of mature CD83+ 
IDC in the stroma of the lesions was significantly higher in 
Kaposi’s sarcoma than in vascular oral lesions (p<0.001).  
Discussion
Kaposi’s sarcoma is a low-grade vascular malignancy 
considered an AIDS-defining disease. Its incidence revealed 
a dramatic increase in the early 1980’s following HIV-
infection outburst worldwide and it is still overrepresented 
in this population, although the development of the highly 
active anti-retroviral therapy (HAART) usually lead to the 
involution of the neoplasm. Kaposi’s sarcoma is also known 
to be tightly associated with HHV-8 infection, which is 
Figure 1. Microscopic and immunohistochemical aspects of oral Kaposi’s sarcoma. A) All cases included in this study were categorized as solid 
Kaposi’s sarcoma and exhibited a spindle cell component with irregular blood vessels with different shapes and sizes (H&E; 50X). B) Higher 
magnification demonstrating the spindle cell component of Kaposi’s sarcomas (H&E; 100X). C) All cases were positive for the vascular marker CD34 
(DAB; 200×) and D) were confirmed to be associated with HHV-8 infection, demonstrated as a nucler staining in the neoplastic cells (DAB; 200×).













Figure 3. Immunohistochemical reactivity against CD207 and CD83 in the epithelium and stroma of oral Kaposi’s sarcoma and of highly vascular 
oral lesions A) CD83 stained mature LC, few cells were observed in the epithelium of AIDS-associated oral Kaposi’s sarcomas (DAB; 100X). B) In 
the stroma of Kaposi’s sarcomas, whereas a higher number of CD83+ IDC (DAB; 100X).   C) In highly vascular oral lesions, the number of CD83+ 
LC was lower than in Kaposi’s sarcoma (DAB; 200×)., and G) a significantly lower number of CD83+ IDC was observed in highly vascular oral 
lesions (DAB; 200×).
Figure 2. Immunohistochemical reactivity against CD207 in the epithelium and stroma of oral Kaposi’s sarcoma and of highly vascular oral lesions 
A) CD207 stained immature LC in the overlying epithelium of oral Kaposis’s sarcoma, revealing the dendritic characteristic of these cells (DAB; 
200×). B) In the stroma of Kaposi’s sarcomas,  CD207+ IDC were very scarce and were observed as round cells without dendritic prolongations 
(DAB; 100×). C) A significantly higher count of CD207+ immature LC were observed in the epithelium of HIV-negative highly vascular oral lesions 
(DAB; 200×), D) whereas a lower count of CD207+ IDC was obtained inside the highly vascular oral lesions (DAB; 200×).






















considered the main etiologic factor for the malignancy, 
despite the exact mechanisms that cause tumor growth 
remains to be fully established (1). Disruptions of systemic 
immunosurvilance are critical for Kaposi’s sarcoma onset, 
but the importance of changes in the distribution and 
function of immune components in the local environment 
of the disease need to be more investigated. Therefore, in 
this study we demonstrated significant differences in the 
distribution of LC and IDC in AIDS-associated oral Kaposi’s 
sarcoma when compared to HIV-negative highly vascular 
oral lesions, suggesting that alterations in the presence of 
these DC may play an important role in the pathogenesis 
of Kaposi’s sarcoma.  
LC are bone marrow derived DC found in the epithelium 
of normal skin and mucosas that encounter invading foreign 
pathogens in these surfaces, transfer to connective tissue 
where they are known as IDC and move toward regional 
lymph nodes where antigens are presented to naïve T 
lymphocytes (8). There is a growing number of evidences 
supporting the hypothesis that different subtypes of DC play 
important roles in the immunosurveillance against neoplastic 
cells and that the distribution and/or the regular function 
of these cellular populations are altered in many human 
tumors including oral cancer, lip cancer, mycosis fungoids, 
cutaneous squamous cell carcinomas, and others (8-11). 
Moreover, different authors have attributed a significant 
prognostic importance for DC in several of these malignant 
neoplasms (12,13), speculating that changes in these cells 
would not only predispose to neoplastic development, but 
it would also represent potential therapeutic targets for 
future chemotherapy schemes.
Our group has previously demonstrated that AIDS 
patients reveal important changes in the distribution of LC 
and IDC in the oral mucosa, predisposing these individuals 
to local opportunistic infections (6,7).  Moreover, both cells 
are important for certain virus infections, including human 
immunodeficiency virus type 1, herpes simplex virus and 
cytomegalovirus (14). In addition, due to the strategic 
localization of these DC in the overlying oral mucosa and 
the well known association of HHV-8 infection with the 
pathogenesis of Kaposi’s sarcoma, we speculate that local 
alterations in the distribution of DC could be associated 
with the onset of this malignant vascular neoplasm. Further 
supporting this hypothesis, Rappocciolo et al. (14) recently 
showed that HHV-8 was capable of infecting three different 
DC types, monocyte-derived DC,  LC and and interstitial 
dermal dendritic cells, resulting in a reduced ability of these 
cells to stimulate allogeneic CD4+ T cells. The authors stated 
that HHV-8 caused DC infections by different receptors, 
ultimately altering their function. This same group 
previously demonstrated that the dendritic cell-specific 
ICAM-3 grabbing nonintegrin (DC-SIGN; CD209) would 
be one of the important receptors for HHV-8 infection of 
myeloid DCs and activated B lymphocyte (15,16). Therefore, 
the effects of HHV-8 on antigen presenting DC, may be 
the cause of the weak T cell responses against HHV-8 
antigens (17).
In this study, we observed a significant decrease in the 
number of CD207+ LC in the epithelium of AIDS-associated 
oral kaposi’s sarcoma when compared to the epithelium 
of non-AIDS highly vascular oral lesions, suggesting that 
not only the function of these cells is altered by the 
viral infection, but also the concentration of this cellular 
population might be decreased. However, it is also possible 
to speculate that the number of these immature LC is not 
disrupted, but only its ability to express CD207, therefore, 
other LC immature- or pan-marker would be recommended 
to confirm these possibilities. Nevertheless, no matter what 
option is taking place, our result is per se important to 
demonstrate the loss of CD207 protein, given its known 
importance as a protective barrier against viral infections, 
like against HIV-1 (18,19); on the other hand, CD207 role 
in HHV-8 immune processing remains obscure and needs 
to be investigated since the effect of different viruses on 
LC may exhibit highly different results (20).
We have also observed that Kaposi’s sarcoma patients 
exhibited a higher number of CD207+ and CD83+ IDC than 
benign lesions, we speculate that it possibly indicates a 
Table 1. Distribution of LC and IDC in different compartments (epithelium and stroma of the lesions) of oral Kaposi’s sarcoma and in highly 
vascular oral lesions (hemangioma and pyogenic granuloma)
Lesions
CD207 CD83















44.2† (37.1) 35 (0 – 142) 17.9 (15.3)† 13 (0 – 62) 8.31 (8.0) 6 (0 – 37) 37.2 (20.9)† 35 (0 – 100)
Highly vascular 
oral lesions *
65.7 (26.4) 63 (18 – 109) 4.2 (2.4) 4 (1 – 11) 6.9 (6.9) 4 (0 – 21) 17.6 (11.0) 16.0 (4 – 46)
*Hemangioma and pyogenic granuloma. †Statistically significant differences.













host response against HIV and/or HHV-8 infections, with 
a higher concentration of immature and activated stromal 
DC being recruted, supposedly from circulating monocytes 
(5). IDC may complement the role of LC by adopting an 
immunostimulatory activity (20).
Although our study represents an original contribution 
to the understanding of LC and IDC importance for Kaposi’s 
sarcoma pathogenesis, several authors have previously 
attempted to investigate the role played by different DC 
subsets in the development of this lesion. We reviewed 
the available literature searching for studies dealing with 
DC and Kaposi’s sarcoma, and Table 2 summarizes the 


















51 cases of KS ; 10 cases of pyogenic 






















Study groups: 15 cases of KS without 
Candida albicans co-infection ; 17 cases 
of KS with Candida albicans co-infection; 
Control groups: 23 cases of non-candida 
and non-HIV infected mucosa overlying 
pleomorphic adenomas ; 19 cases of 
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15 cases of HIV+ KS
19 cases of oral mucosa of HIV+ patients
















































IHC CD83 + ; CD207 +
KS revealed a significantly lower CD207+ 
immature LC count and an increased CD207+ 
IDC than benign vascular oral lesions. 
Moreover, KS also showed an increased 
number of mature CD83+ IDC than benign 








HLA-DR CD1a CD11b CD14 CD91 
CD80; CD86 CD83 ; CD209 CD207
HHV-8 can target both LC and iDDC for 
productive infection via different receptors and 
alter their function, supporting their potential 









BDCA-2 + ; MxA + (to evaluate 
interferon production)
pDCs are recruited
into the skin lesions of classic KS, but there is 
a significantly lower plasmacytoid cells and 












BCDA4+ ; BDCA2+ ; CD303+ ; 
CD123+ ; CD83-/+ ; CD86-/+
KSHV can infect and activate human pDCs, as 
measured by upregulation of CD83 and CD86, 
and by IFN-α secretion. Induction of IFN-α 






HLA-DR + ; CD3 - ;  CD19 - ; CD20 - ; CD16 - ; 
CD14 - ;  CD11c + ; CD123 + ; CD80 -/+ ; CD83 
-/+ ; CD86 -/+ ;  CD49c -/+ ; CD91 -/+ ;  CD34 
-/+ ; CD14 -/+  ; CD1a + ; CD40+ ; ILT2, 3, 4 +
PBDC (both myeloid, plasmacytoid and 
monocytes) in cKS patients were significantly 
lower than controls, and was more severe in 
more advanced cases. PBDC expressing the 
HHV8 receptor CD49c was higher in cKS 






CD3 - ; CD14 - ; CD16 - ; CD19 - ; HLA-DR + ; 
CD11c -/+ ; CD1a ; CD80 ; CD83 ; CD40 ; CD91
Despite the impaired functional capacity of DC 
in patients with KS, they retained the ability 
of activating and stimulating CD8 cytotoxic 
T cells. Plasmacytoid DCs were depleted in 









Less than 1% of the spindle cells cultured 
were positive for CD1a. Spindle cell cultures 
have nearly always given rise to cells with 
fibroblastic and/or smooth muscle cell 







The number of HLA-DR+ cells was increased in 
patch-like and nodular KS compared to HIV+ 
and HIV- normal mucosa.
Kanitakis et 
al., 1992
France IHC Factor XIIIa + ;  Antigen H -
Dermal dendrocytes density tended to be 
decreased in  immunosuppression-associated 
Kaposi’s sarcoma when compared with classical 
form. The results do not support dermal 
dendrocytes as being the cells of origin of 
Kaposi’s sarcoma. Decreased density of dermal 




investigations encountered. The diversity of molecules 
expressed by each DC not only makes their mechanisms 
more complex, but also impairs appropriate comparisons 
among studies that used different markers to identify DC. 
The first investigations of DC in Kaposi’s sarcomas used the 
unspecific proteins HLA-DR (21) and factor XIIIa to stain 













dendrocytes, but CD1 (22,23) has been the most used DC 
marker, although it does not discriminate between mature 
and immature subpopulations. Using CD1a Jivan et al. (24) 
(2016) recently showed a lower count of LC in non-Candida 
infected oral kaposi’s sarcoma than in uninfected normal 
mucosa. Interestingly, plasmocytoid DC (pDC) has been the 
most studied subpopulation in Kaposi’s sarcoma given its 
ability to recognize single-stranded RNA and unmethylated 
CpG motifs associated with viral infection, inducing an 
antiviral response within the host and a high production 
of interferon (25-27). Similar to our study, Stebbing et al. 
(28) using HIV-1 infected patients, also showed a depletion 
of pDC in Kaposi’s sarcoma patients compared with Kaposi’s 
sarcoma-negative individuals, whereas Karouni et al. (29) 
observed a significantly lower pDC count and a lower 
interferon production in classic kaposi’s sarcoma than in 
mollusccum contagious cases. 
Although we did not correlate the distribution of LC 
and IDC observed in Kaposi’s sarcoma patients with their 
respective CD4 count since this data were unavailable for 
consultation, potentially representing a limitation of our 
study, Grulich et al. (30) stated that CD4 count could be 
an insensitive indicator of immune deficiency, because its 
count might not be an accurate or unbiased measure of 
immune function. It is also important to consider that the 
distribution of LC may vary according to different intraoral 
subsites, therefore, it remains to be determined if Kaposi’s 
sarcomas biopsied in different oral locations could have 
interfered in our DC count. 
In conclusion, we observed a reduction of CD207+ 
immature LC and an increase of CD207+ and CD83+ IDC 
in AIDS-associated Kaposi’s sarcoma than in HIV-negative 
vascular oral lesions, suggesting that alterations in the 
distributions of these DC subsets, either because HIV and/
or HHV-8 effect, may play a role in the pathogenesis of 
this malignant vascular neoplasm. 
Resumo
O objetivo deste estudo foi determinar se a distribuição das células de 
Langerhans (CL) e das células dendríticas intersticiais (CDI) está alterada 
no sarcoma de Kaposi oral associado à AIDS quando comparado às 
lesões orais altamente vasculares HIV-negativas. 51 casos de sarcoma de 
Kaposi oral associado à AIDS e 20 de lesões orais altamente vasculares 
foram recuperados retrospectivamente. Todos os casos de sarcoma de 
Kaposi foram confirmados pela positividade para os anticorpos CD34 e 
HHV-8. Dados clínicos sobre sexo, idade e localização das lesões foram 
obtidos dos laudos histopatológicos. Foram realizadas imunoistoquímica 
contra CD207 (células dendríticas imaturas) e CD83 (células dendríticas 
maduras). As CL estavam presentes no epitélio enquanto as CDI estavam 
presentes no estroma. As células CD207+ predominaram no epitélio das 
lesões, enquanto as células CD83+ predominaram no estroma. O sarcoma 
de Kaposi teve uma contagem mais baixa de CD imaturas CD207+ (p = 
0,02) e número aumentado de CDC CD207+ do que lesões orais altamente 
vasculares (p<0,001). Além disso, o sarcoma de Kaposi também mostrou um 
número aumentado de CDI CD83+ maduras do que lesões orais altamente 
vasculares (p<0,001). Houve alterações significativas na distribuição de 
CL e CDI no sarcoma de Kaposi associado à AIDS quando comparado 
às lesões orais vasculares HIV-negativas, sugerindo que alterações na 
distribuição das mesmas podem desempenhar um papel na patogênese 
do sarcoma de Kaposi.
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